The following Pantai Premier Pathology laboratory branches have successfully completed the external accreditation assessment in quarter 1 of 2023:-
- Bangsar Branch has completed the re-assessment and extension scope from 5 to 6 January 2023 and 7 to 8 February 2023 and received the MS ISO 15189 certification,
- Klang Branch has completed the re-assessment and extension scope from 3 to 31 January 2023 and received the MS ISO15189 certification,
- Cytogenetic and Molecular Diagnostics Laboratory (CMDL) has completed the assessment from 16 to 17 February 2023 and received the College of American Pathologists (CAP) Accreditation,
- Cheras Branch has completed the re-assessment and extension scope from 1 to 2 March 2023 and received the MS ISO 15189 certification,
- Reference Core Lab (RCL) completed the surveillance from 7 to 8 March 2023 and received the MS ISO 15189 certification.
This external assessment is a comprehensive process that examines all of the laboratory management and technical aspects. The laboratories from the branches stated have demonstrated their commitment to high standards of performance, accountability, and continuous improvement. Pantai Premier Pathology would like to express its heartfelt gratitude to all the employees and stakeholders for their steadfast commitment and invaluable contributions and are eager to work together to cultivate a culture of quality moving forward.
